Uzbekistan Pharmaceuticals and Healthcare Report

 Published On: Feb, 2014 |    No of Pages: 86 |  Published By: BMI Pharmaceuticals and Healthcare | Format: PDF   |   Request Free Sample

View: There have been a number of positive developments in international cooperation forUzbekistan's pharmaceutical sector in recent months. Having identified the pharmaceutical sector as a keyarea of economic growth, the Uzbek government has been encouraging domestic production ofpharmaceuticals. We note that it has seen some success with this - with an increase of exports reported in2013. However, we project that the pharmaceutical trade balance will remain in negative territory for theforeseeable future, with substantial improvements yet to be made to regulatory and manufacturingstandards, potentially curtailing further growth.
Headline Expenditure Projections
- Pharmaceuticals: UZS933.7bn (US$504mn) in 2013 to UZS1,218.5bn (US$520mn) in 2014; 30.5% inlocal currency terms and 3.0% in US dollar terms.
- Healthcare: UZS7,013.8bn (US$3.35bn) in 2013 to UZS8,584.3bn (US$3.66bn) in 2014; 22.4% in localcurrency terms and 9.1% in US dollar terms.

Industry View 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Uzbekistan Pharmaceutical Sales, Historical Data and Forecasts 12
Healthcare Market Forecast 13
Table: Uzbekistan Healthcare Expenditure Trends, Historical Data And Forecasts 15
Table: Uzbekistan Government Healthcare Expenditure Trends, Historical Data And Forecasts 15
Table: Uzbekistan Private Healthcare Expenditure Trends, Historical Data And Forecasts 16
Prescription Drug Market Forecast 16
Table: Uzbekistan Prescription Drug Market Indicators, Historical Data And Forecasts 17
Patented Drug Market Forecast 18
Table: Uzbekistan's Patented Drug Market Indicators, Historical Data And Forecasts 19
Generic Drug Market Forecast 19
Table: Uzbekistan's Generics Drug Market Indicators, Historical Data And Forecasts 20
OTC Medicine Market Forecast 20
Table: Uzbekistan Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 21
Pharmaceutical Trade Forecast 22
Table: Uzbekistan Pharmaceutical Trade Data And Forecasts (US$mn) 24
Other Healthcare Data 25
Key Risks To BMI's Forecast Scenario 26
Macroeconomic Forecasts 28
Economic Analysis 28
Table: Uzbekistan - Economic Activity 31
Industry Risk Reward Ratings 32
Central And Eastern Europe Risk/Reward Ratings 32
Uzbekistan Risk/Reward Ratings 38
Rewards 38
Risks 39
Market Overview 41
Industry Trends And Developments 43
Epidemiology 43
Healthcare Sector 45
Healthcare Provision 46
Health Insurance Sector 48
Healthcare Sector Reforms 49
Research And Development (R&D) 50
Clinical Trials 50
International Cooperation 51
Regulatory Development 53
Counterfeit Drugs 54
Intellectual Property Rights 54
Pricing And Reimbursement 55
Competitive Landscape 57
Domestic Pharmaceutical Industry 57
Leading Domestic Players 59
Table: List Of Companies In Uzpharmsanoat SJSC (as of April 20 2011) 60
Pharmaceutical Sector Reforms 61
Foreign Pharmaceutical Industry 62
Recent Pharmaceutical Industry Developments 63
Pharmaceutical Wholesale 65
Pharmaceutical Retail 65
Company Profile 67
Jurabek Laboratories 67
Uzpharmsanoat 70
Asklepiy Pharmaceutical Company 73
Demographic Forecast 75
Table: Uzbekistan's Population By Age Group, 1990-2020 ('000) 76
Table: Uzbekistan's Population By Age Group, 1990-2020 (% of total) 77
Table: Uzbekistan's Key Population Ratios, 1990-2020 78
Table: Uzbekistan's Rural And Urban Population, 1990-2020 78
Glossary 79
Methodology 81
Pharmaceutical Expenditure Forecast Model 81
Healthcare Expenditure Forecast Model 81
Notes On Methodology 82
Risk/Reward Ratings Methodology 83
Ratings Overview 84
Table: Pharmaceutical Risk/Reward Ratings Indicators 84
Indicator Weightings 85

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.